Atrial Flutter – Global Drug Forecast and Market Analysis of Worldwide Industry Size, Share, Trends, Research Report and Growth

Transcription

Atrial Flutter – Global Drug Forecast and Market Analysis of Worldwide Industry Size, Share, Trends, Research Report and Growth
[email protected]
Atrial Flutter – Global Drug Forecast and
Market Analysis of Worldwide Industry Size,
Share, Trends, Research Report and Growth
Atrial Fibrillation (AF) is the most common type of arrhythmia that causes an irregular and often fast heart
rhythm. Over the past two decades, an increasing prevalence of atrial fibrillation cases is seen across the
globe.
Clinical trial report, " Atrial Flutter Global Clinical Trials Review, H1, 2016 " provides Various therapeutic
options to treat patients with AF, and most patients will receive some form of antithrombotic therapy, a heart
rate control agent, and potentially, an antiarrhythmic drug for rhythm control.
Browse detailed TOC, Tables, figures, Charts and Companies mentioned in Atrial Flutter Global
Clinical Trials Review Report at- http://www.marketreportsworld.com/atrial-flutter-global-clinical-trialsreview-h1-2016-10105132
The increasing number of people suffering from atrial fibrillation is the major driving force for this market.
Favourable regulations are supporting the increasing use of catheter and surgical ablation treatments for
AF. Larger prevalence of atrial fibrillation and lower treatment cost would support the increasing number of
atrial fibrillation surgical and catheter ablation procedures in countries like France.
The report also enhances the decision making capabilities and helps to create an effective counter strategy
to gain competitive advantage.
Request sample
sample/10105132
PDF
of
this
report
at-
http://www.marketreportsworld.com/enquiry/request-
Keyplayers in Atrial Flutter Global Clinical Trials Review, H1, 2016 are as follows:
Sanofi
Cardiome Pharma Corp.
Astellas Pharma Inc.
Abbott Laboratories
Medtronic plc
Laguna Pharmaceuticals Inc.
The market leaders in the global atrial fibrillation market are involved in constant attempts for the
development of innovative methodologies which would increase the efficiency and accuracy of atrial
fibrillation diagnosis while providing the efficient processing of the overall treatment.
+1 408 520 9750
www.marketreportsworld.com
[email protected]
[email protected]
About Market Reports World:
Market Reports World is the credible source for gaining the market research reports that will exponentially
accelerate your business. We are among the leading report resellers in the business world committed
towards optimizing your business. The reports we provide are based on a research that covers a magnitude
of factors such as technological evolution, economic shifts and a detailed study of market segments.
Contact–
Mr. Ameya Pingaley
Market Reports World
+1-408 520 9750
Email – [email protected]
Website: www.marketreportsworld.com
+1 408 520 9750
www.marketreportsworld.com
[email protected]

Similar documents

Global Left Atrial Appendage (LAA) Closure Market 2016 Market Size,Share, trends and Forecast 2016

Global Left Atrial Appendage (LAA) Closure Market 2016 Market Size,Share, trends and Forecast  2016 The left atrial appendage (LAA) is a small ear-shaped sac in the muscle wall of the top left chamber of the heart that controls the electrical impulses during atrial fibrillation. LAA closure device is an interventional device used to prevent stroke, reduce the risk of secondary stroke and emboli because of atrial fibrillation.

More information